According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

Short interval circulating tumor DNA (ctDNA) kinetics as a predictor of tumor response in patients with gastrointestinal (GI) cancer receiving immune checkpoint inhibitor (ICI)-based treatment. This ...

Investigating the tumor microenvironment and neoadjuvant therapy response in HER2-positive breast cancer with invasive micropapillary carcinoma component. This is an ASCO Meeting Abstract from the ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Within the realm of genetic regulation, chromatin modifications such as histone methylation and acetylation play pivotal roles in the transcriptional control of genes. Disruptions in these processes ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...

Krystal Biotech reports positive clinical data for KB408 and KB407, demonstrating safety and efficacy in AATD and cystic fibrosis patients. Krystal Biotech, Inc. has announced promising clinical ...

According to MarketsandMarkets, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 to USD 5.93 billion ...